UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

Molecular cancer, 2020-12, Vol.19 (1), p.171-18, Article 171

2020

Volltextzugriff (PDF)

Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

Oncogene, 2020-10, Vol.39 (42), p.6556-6571

2020

Volltextzugriff (PDF)

BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts

International journal of oncology, 2015-08, Vol.47 (2), p.719-727

2015

Volltextzugriff (PDF)

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

Cancer treatment reviews, 2014-02, Vol.40 (1), p.31-40

2014

Volltextzugriff (PDF)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer

Asian Journal of Urology, 2020-07, Vol.7 (3), p.203-218

2020

Volltextzugriff (PDF)

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Oncogene, 2019-06, Vol.38 (24), p.4875-4884

2019

Volltextzugriff (PDF)

Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China: A nationwide, multi-center, population-based cross-sectional study

Chinese medical journal, 2024-06, Vol.137 (11), p.1324-1331

2024

Volltextzugriff (PDF)

P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC

Journal of experimental & clinical cancer research, 2023-08, Vol.42 (1), p.1-215, Article 215

2023

Volltextzugriff (PDF)

Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients

Frontiers in genetics, 2020-11, Vol.11, p.567200-567200

2020

Volltextzugriff (PDF)

Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

The Prostate, 2013-09, Vol.73 (12), p.1306-1315

2013

Volltextzugriff (PDF)

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal

Cancer reports, 2023-08, Vol.6 (8), p.e1824-n/a

2023

Volltextzugriff (PDF)

Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Oncogene, 2019-06, Vol.38 (24), p.4885-4885

2019

Volltextzugriff (PDF)

YAP is required for prostate development, regeneration, and prostate stem cell function

Cell death discovery, 2023-09, Vol.9 (1), p.339-339, Article 339

2023

Volltextzugriff (PDF)

ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis

Cancer letters, 2018-12, Vol.439, p.47-55

2018

Volltextzugriff (PDF)

Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer

The American journal of pathology, 2015-02, Vol.185 (2), p.293-301

2015

Volltextzugriff (PDF)

Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer

Oncogene, 2024-09, Vol.43 (38), p.2835-2849

2024

Volltextzugriff (PDF)

Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer

World journal of urology, 2022-11, Vol.40 (11), p.2817-2824

2022

Volltextzugriff (PDF)

Functional roles of antisense enhancer RNA for promoting prostate cancer progression

Theranostics, 2021, Vol.11 (4), p.1780-1794

2021

Volltextzugriff (PDF)

Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL

The Prostate, 2024-03, Vol.84 (4), p.376-388

2024

Volltextzugriff (PDF)

Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20ng/mL

The Prostate, 2024-03, Vol.84 (4), p.376-388

2024

Volltextzugriff (PDF)

ASC-J9® , and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals

Cancer letters, 2016-07, Vol.376 (2), p.377-386

2016

Volltextzugriff (PDF)

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

The Journal of clinical investigation, 2021-07, Vol.131 (14)

2021

Volltextzugriff (PDF)

Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification

Theranostics, 2023-01, Vol.13 (2), p.596-610

2023

Volltextzugriff (PDF)

Primary teratoma of the adrenal gland: a case report

Translational cancer research, 2022-08, Vol.11 (8), p.2985-2989

2022

Volltextzugriff (PDF)

Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells

Molecular carcinogenesis, 2016-12, Vol.55 (12), p.2278-2290

2016

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Englisch
(97)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Clinical Investigation
(6)
Oncogene
(4)
The Prostate
(3)
Theranostics
(3)
Acs Central Science
(2)
Analytical Methods
(2)
Bmc Psychiatry
(2)
Cancer Letters
(2)
Drug Delivery And Translational Research
(2)
Heliyon
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China: A nationwide, multi-center, population-based cross-sectional study

P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC

Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients

Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal

Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

YAP is required for prostate development, regeneration, and prostate stem cell function

ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis

Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer

Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer

Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer

Functional roles of antisense enhancer RNA for promoting prostate cancer progression

Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL

Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20ng/mL

ASC-J9® , and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification

Primary teratoma of the adrenal gland: a case report

Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells

Suchergebnisse filtern